MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

La Jolla Pharmaceutical Company Company Profile (NASDAQ:LJPC)

Consensus Ratings for La Jolla Pharmaceutical Company (NASDAQ:LJPC) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $45.50 (188.34% upside)

Analysts' Ratings History for La Jolla Pharmaceutical Company (NASDAQ:LJPC)
Show:
DateFirmActionRatingPrice TargetActions
5/24/2016Lake Street CapitalInitiated CoverageBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/9/2016Cowen and CompanyInitiated CoverageOutperform$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/19/2016Noble FinancialReiterated RatingBuy$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/8/2015Chardan CapitalBoost Price TargetBuy$60.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2015HC WainwrightLower Price TargetBuy$29.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015OppenheimerInitiated CoverageOutperform$43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015Jefferies GroupInitiated CoverageBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/15/2014WedbushReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/24/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha